Meeting
2023 ASCO Genitourinary Cancers Symposium
68Ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly Study): Preliminary results.
Authors
Charlotte Hawkins
Telix Pharmaceuticals, Fishers, IN
Charlotte Hawkins , Olivia Pocha , Elisa M. Ledet , Alexandra Lieberman , Jennifer Schwartz , Maddie Hawkins , Priya Bhandari , Pedro C. Barata , Ellen B. Jaeger , Jodi Lyn Layton , Brian E. Lewis , Kendra Marie Harris , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Diagnostics and Imaging
Clinical Trial Registration Number
NCT04854369
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 54)
DOI
10.1200/JCO.2023.41.6_suppl.54
Abstract #
54
Poster Bd #
C16
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Genitourinary Cancers Symposium
68ga-PSMA-11 patients with newly diagnosed and recurrent prostate cancer (Firefly).
First Author: Charlotte Manogue
Poster
2023 ASCO Annual Meeting
PSMA PET guided salvage radiotherapy among patients with prostate cancer in the post-prostatectomy setting: A single center post-hoc analysis.
First Author: Clayton P Smith
Poster
2023 ASCO Genitourinary Cancers Symposium
Development and validation of a multi-institutional nomogram of outcomes for PSMA-PET–based salvage radiotherapy in recurrent prostate cancer.
First Author: Constantinos Zamboglou
Poster
2023 ASCO Genitourinary Cancers Symposium
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: A post hoc analysis of the PROPS trial.
First Author: Samuel Tremblay